IHT Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $983K | Sell |
15,339
-213
| -1% | -$13.7K | 0.03% | 506 |
|
|
2025
Q1 | $987K | Buy |
15,552
+4,352
| +39% | +$276K | 0.03% | 476 |
|
|
2024
Q4 | $745K | Sell |
11,200
-924
| -8% | -$61.5K | 0.02% | 546 |
|
|
2024
Q3 | $847K | Buy |
12,124
+1,550
| +15% | +$108K | 0.02% | 547 |
|
|
2024
Q2 | $685K | Buy |
10,574
+5,614
| +113% | +$364K | 0.03% | 537 |
|
|
2024
Q1 | $321K | Buy |
4,960
+192
| +4% | +$12.4K | 0.01% | 776 |
|
|
2023
Q4 | $314K | Buy |
4,768
+1,059
| +29% | +$69.7K | 0.01% | 750 |
|
|
2023
Q3 | $212K | Buy |
3,709
+271
| +8% | +$15.5K | 0.01% | 862 |
|
|
2023
Q2 | $211K | Sell |
3,438
-225
| -6% | -$13.8K | 0.01% | 862 |
|
|
2023
Q1 | $230K | Buy |
3,663
+90
| +3% | +$5.65K | 0.01% | 799 |
|
|
2022
Q4 | $227K | Sell |
3,573
-380
| -10% | -$24.1K | 0.01% | 774 |
|
|
2022
Q3 | $233K | Buy |
+3,953
| New | +$233K | 0.02% | 718 |
|
|
2018
Q2 | – | Sell |
-330
| Closed | -$16K | – | 1069 |
|
|
2018
Q1 | $16K | Hold |
330
| – | – | ﹤0.01% | 1049 |
|
|
2017
Q4 | $16K | Hold |
330
| – | – | ﹤0.01% | 1055 |
|
|
2017
Q3 | $17K | Hold |
330
| – | – | 0.01% | 821 |
|
|
2017
Q2 | $1 | Hold |
330
| – | – | ﹤0.01% | 1340 |
|
|
2017
Q1 | $14K | Hold |
330
| – | – | 0.01% | 741 |
|
|
2016
Q4 | $13K | Buy |
+330
| New | +$13K | 0.01% | 748 |
|